Article

Update on the use of hydroxyurea for the early management of chronic-phase- chronic myeloid leukemia: data from a real-world cohort

2026-07-28

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Hydroxyurea (HU) is sometimes used before confirmation of the diagnosis of chronic-phase chronic myeloid leukemia (CP-CML) and treatment with tyrosine kinase inhibitors (TKI). The limited literature data suggest that this strategy does not offer any benefit, but no large-scale study has been conducted on this subject. <bold>Methods:</bold> From the French...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 70cee4d8-2e78-5b01-95b9-cc0a24fed7f2
DOI: 10.21203/rs.3.rs-10088268/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Update on the use of hydroxyurea for the early management of chronic-phase- chronic myeloid leukemia: data from a real-world cohortDOI 10.21203/rs.3.rs-10088268/v1Read

Best First Line Tyrosine Kinase Inhibitor for Chronic Phase Chronic Myeloid Leukemia in Adults: A Network Meta-AnalysisSemantic proximity Read

Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on behalf of the Polish Adult Leukaemia GroupSemantic proximity Read

Safety and Efficacy of TKIs in Very Elderly Patients (≥75 Years) with Chronic Myeloid LeukemiaSemantic proximity Read

A review of the European LeukemiaNet recommendations for the management of CML.Semantic proximity Read

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in OncologySemantic proximity Read

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.Semantic proximity Read

[Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia].Semantic proximity Read

Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemia.Semantic proximity Read

Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials.Semantic proximity Read

Treatment and molecular monitoring update in chronic myeloid leukemia management.Semantic proximity Read

Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionSemantic proximity Read

The impact of pretransplant use of tyrosine kinase inhibitors on allogeneic stem cell transplantation in patients with chronic myeloid leukemia - A single-institution retrospective studySemantic proximity Read